伊力特(600197.SH):控股股東可交換公司債完成摘牌
格隆匯 8 月 20日丨伊力特(600197.SH)公佈,公司近日接到控股股東新疆伊力特集團有限公司(“伊力特集團”)的通知,伊力特集團2018年非公開發行可交換公司債券(債券代碼:137057,債券簡稱:18伊力EB),已於2020年8月20日在上海證券交易所摘牌。
伊力特集團非公開發行的4億元可交債自2018年8月20日進入換股期至2020年8月10日已全部交換成公司股票,累計換股2536.54萬股,因此導致伊力特集團持有的公司股份被動減持至19736.35萬股,佔公司截止2020年7月1日總股本43444.49萬股的45.43%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.